← Eichor
Condition: Hyperthermic Intraperitoneal Chemotherapy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hyperthermic Intraperitoneal Chemotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Su
NA · 7 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06351475A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperth
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06685887Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Phase 2 · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05913674Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer
Phase 2 · 1 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04282356PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER
Phase 2 · 1 location(s) · Banner Health · NCT07178808Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04847063Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)
Phase 3 · 1 location(s) · University of Southampton · NCT06513065Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With
NA · 2 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07493876Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
Phase N/A · 2 location(s) · Technische Universität Dresden · NCT05652348Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06475261Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Phase N/A · 1 location(s) · Oslo University Hospital · NCT02073500The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cy
Phase 1/Phase 2 · 1 location(s) · The Netherlands Cancer Institute · NCT07460180Proactive Hemodynamic Management During Cytoreductive Surgery and HIPEC
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07070973Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Phase N/A · 1 location(s) · Jules Bordet Institute · NCT07451483HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Phase 2 · 1 location(s) · Instituto Nacional de Cancerologia de Mexico · NCT03275194Efficacy of Hyperthermic Intraperitoneal Chemotherapy
Phase 3 · 5 location(s) · Uppsala University · NCT04861558Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05415709Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Can
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05123807An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT02754115Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Phase 2 · 1 location(s) · Mayo Clinic · NCT04858009The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Per
Phase 2 · 2 location(s) · Shanghai Zhongshan Hospital · NCT06946901Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Periton
Phase 2 · 1 location(s) · Mayo Clinic · NCT05753306Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence
Phase 3 · 1 location(s) · Jagiellonian University · NCT04597294A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Phase 2 · 13 location(s) · Memorial Sloan Kettering Cancer Center · NCT06057935To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating P
NA · 3 location(s) · Unidade Local de Saúde São João · NCT07493421A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patient
Phase 2 · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT07229040A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherap
NA · 1 location(s) · Yale University · NCT07291180Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Ad
Phase 3 · 1 location(s) · Maimónides Biomedical Research Institute of Córdoba · NCT06783491Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06709404One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei
NA · 1 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT07328737
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.